These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1141218)

  • 1. The activation of coagulation factor X. Identity of cleavage sites in the alternative activation pathways and characterization of the COOH-terminal peptide.
    Jesty J; Spencer AK; Nakashima Y; Nemerson Y; Konigsberg W
    J Biol Chem; 1975 Jun; 250(12):4497-504. PubMed ID: 1141218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.
    Radcliffe R; Nemerson Y
    J Biol Chem; 1976 Aug; 251(16):4749-802. PubMed ID: 956165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical characterization of a mouse immunoglobulin A heavy chain with a 100-residue deletion. Amino acid and carbohydrate compositions and NH2-and COOH-terminal sequences.
    Robinson EA; Smith DF; Appella E
    J Biol Chem; 1974 Oct; 249(20):6605-10. PubMed ID: 4472818
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural studies on bovine prothrombin. Isolation and partial characterization of the Ca2+ binding and carbohydrate containing peptides of the N-terminus region.
    Benson BJ; Hanahan DJ
    Biochemistry; 1975 Jul; 14(14):3265-77. PubMed ID: 1170888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex.
    Baugh RJ; Krishnaswamy S
    J Biol Chem; 1996 Jul; 271(27):16126-34. PubMed ID: 8663201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the structural difference between bovine blood coagulation factors X1 and X2 to tyrosine 18 in the activation peptide.
    Morita T; Jackson CM
    J Biol Chem; 1986 Mar; 261(9):4008-14. PubMed ID: 3949800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein.
    Han YN; Komiya M; Kato H; Iwanaga S; Suzuki T
    FEBS Lett; 1975 Oct; 57(3):254-8. PubMed ID: 1181197
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative chemical analyses of the alloantigenic fragments of HL-A antigens.
    Henriksen O; Appella E; Smith DF; Tanigaki N; Pressman D
    J Biol Chem; 1976 Jul; 251(14):4214-9. PubMed ID: 932029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma.
    Rabiet MJ; Blashill A; Furie B; Furie BC
    J Biol Chem; 1986 Oct; 261(28):13210-5. PubMed ID: 3759958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X. The role of the carbohydrate moieties in the activation of factor X.
    Inoue K; Morita T
    Eur J Biochem; 1993 Nov; 218(1):153-63. PubMed ID: 8243461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the carbohydrate structure of bovine milk galactosyltransferase.
    Lehman ED; Hudson BG; Ebner KE
    FEBS Lett; 1975 Jun; 54(1):65-9. PubMed ID: 805714
    [No Abstract]   [Full Text] [Related]  

  • 13. Bovine factor VII. Its purification and complete amino acid sequence.
    Takeya H; Kawabata S; Nakagawa K; Yamamichi Y; Miyata T; Iwanaga S; Takao T; Shimonishi Y
    J Biol Chem; 1988 Oct; 263(29):14868-77. PubMed ID: 3049594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of equine submaxillary mucin. Possible carbohydrate-peptide linkage.
    Huser H; Mody E; Faillard H
    Hoppe Seylers Z Physiol Chem; 1973 Jul; 354(7):749-59. PubMed ID: 4803508
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex.
    Kumar A; Blumenthal DK; Fair DS
    J Biol Chem; 1991 Jan; 266(2):915-21. PubMed ID: 1985971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
    Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
    J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on fetuin from foetal bovine serum. The composition and amino acid sequences of glycopeptides from fetuin.
    Begbie R
    Biochim Biophys Acta; 1974 Dec; 371(2):549-76. PubMed ID: 4139976
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbohydrate components of the glycopeptides of ovine lutropin.
    Chu WP; Liu WK; Ward DN
    Biochim Biophys Acta; 1976 Jul; 437(2):377-83. PubMed ID: 782529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies on a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
    Bhattacharyya SN; Sahu S; Lynn WS
    Biochim Biophys Acta; 1976 Mar; 427(1):91-106. PubMed ID: 1260011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.